Glaucoma 2026: Which emerging technologies will change practice?
Shownotes
Joel Schuman, MD, of Wills Eye Hospital in Philadelphia, sits down with Sheryl Stevenson, executive editor of the Eye Care Network, for a discussion about emerging technologies that may influence glaucoma care as clinicians look toward 2026.
Schuman highlights artificial intelligence for imaging and risk prediction, noting that “the performance really rivals expert readers and the regulatory pathways are clear.” He also reviews remote monitoring, sustained-release drug delivery, and procedural innovations such as direct selective laser trabeculoplasty.
Addressing adoption challenges, Schuman outlines evidence, workflow, economics, and interoperability as key factors, noting that “The winners don’t have to be the flashiest tools in 2026. They’ll be the ones that make a busy clinic run better.”
Schuman highlights artificial intelligence for imaging and risk prediction, noting that “the performance really rivals expert readers and the regulatory pathways are clear.” He also reviews remote monitoring, sustained-release drug delivery, and procedural innovations such as direct selective laser trabeculoplasty.
Addressing adoption challenges, Schuman outlines evidence, workflow, economics, and interoperability as key factors, noting that “The winners don’t have to be the flashiest tools in 2026. They’ll be the ones that make a busy clinic run better.”